SILO RSI Chart
Last 7 days
19.6%
Last 30 days
2.6%
Last 90 days
29.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 1.7M | 2.0M | 1.9M | 1.7M |
2022 | 1.3M | 1.1M | 1.2M | 1.5M |
2021 | 1.4M | 1.4M | 1.5M | 1.6M |
2020 | 642.4K | 853.8K | 1.1M | 1.3M |
2019 | 0 | 0 | 0 | 431.0K |
2018 | 0 | 0 | 0 | 0 |
2017 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 05, 2024 | weisblum eric | bought | 812 | 2.03 | 400 | ceo and president |
Apr 04, 2024 | weisblum eric | bought | 1,176 | 1.96 | 600 | ceo and president |
Apr 01, 2024 | weisblum eric | bought | 2,101 | 1.91 | 1,100 | ceo and president |
Mar 28, 2024 | weisblum eric | bought | 6,611 | 1.94 | 3,408 | ceo and president |
Dec 20, 2023 | weisblum eric | bought | 322 | 1.61 | 200 | ceo and president |
Dec 19, 2023 | weisblum eric | bought | 815 | 1.63 | 500 | ceo and president |
Dec 15, 2023 | weisblum eric | bought | 1,368 | 1.52 | 900 | ceo and president |
Dec 14, 2023 | weisblum eric | bought | 300 | 1.5 | 200 | ceo and president |
Dec 07, 2023 | weisblum eric | bought | 440 | 1.36 | 324 | ceo and president |
Dec 06, 2023 | weisblum eric | bought | 101 | 1.34 | 76.00 | ceo and president |
Which funds bought or sold SILO recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | Mariner, LLC | sold off | - | - | 1,000,000 | -% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | sold off | -100 | -18,415 | - | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | reduced | -36.75 | -1,448 | 8,642 | -% |
May 15, 2024 | STATE STREET CORP | unchanged | - | 6,000 | 24,000 | -% |
May 13, 2024 | GEODE CAPITAL MANAGEMENT, LLC | unchanged | - | 7,766 | 31,063 | -% |
May 13, 2024 | UBS Group AG | reduced | -98.86 | -46,565 | 729 | -% |
May 13, 2024 | FWL INVESTMENT MANAGEMENT, LLC | unchanged | - | 41.00 | 156 | -% |
May 10, 2024 | JPMORGAN CHASE & CO | new | - | 2.00 | 2.00 | -% |
May 10, 2024 | VANGUARD GROUP INC | unchanged | - | 8,329 | 31,850 | -% |
May 10, 2024 | WELLS FARGO & COMPANY/MN | reduced | -15.00 | 4.00 | 33.00 | -% |
Unveiling Silo Pharma Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Silo Pharma Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Silo Pharma Inc. News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -100.0% | - | 452,332 | 338,164 | 570,295 | 365,270 | 650,070 | 402,190 | 248,179 | 196,248 | 324,473 | 331,419 | 501,495 | 671,570 | 448,692 | 225,815 | 2,937 | 77,933 | 70,948 | 63,962 | 56,977 | 49,991 |
Cost Of Revenue | 0% | 1,460 | 1,460 | 1,459 | 1,459 | 1,460 | 1,460 | 1,459 | 1,459 | 1,460 | 1,460 | 1,459 | 1,460 | 625 | - | - | 1,333 | 84.00 | - | - | - | - |
Gross Profit | 0% | 16,566 | 16,566 | 16,566 | 16,566 | 16,566 | 16,566 | 16,566 | 16,566 | 16,566 | 16,566 | 16,566 | 16,566 | 16,563 | -123,132 | -13,164 | 883 | 210 | - | 186 | - | - |
Operating Expenses | -24.1% | 896,079 | 1,180,290 | 789,964 | 1,131,551 | 820,051 | 1,673,524 | 965,720 | 510,851 | 543,825 | 958,982 | 480,508 | 453,415 | 917,699 | 538,630 | 558,893 | 997,576 | 159,568 | 336,453 | 242,693 | 189,874 | 174,565 |
S&GA Expenses | - | 64,362 | - | - | 239,100 | 64,966 | 104,175 | 60,341 | 25,918 | 36,825 | 21,600 | 24,618 | 45,706 | 71,029 | 5,666 | 7,598 | 30,653 | 17,038 | 11,326 | 44,553 | 18,845 | 12,289 |
R&D Expenses | -5.6% | 318,240 | 336,965 | 174,495 | 130,719 | 202,913 | 634,684 | 375,795 | 105,676 | 170,279 | 475,948 | 70,514 | 98,846 | 48,602 | - | - | - | - | - | - | - | - |
EBITDA Margin | 2.9% | -2.04 | -2.10 | -2.20 | -2.29 | -2.53 | -2.61 | -2.81 | 3.80 | 3.30 | 2.62 | -1.76 | -1.86 | -1.83 | - | - | - | - | - | - | - | - |
Interest Expenses | 585.0% | 1,870 | 273 | 1,078 | 1,863 | 1,655 | 426 | 981 | 377 | 415 | 5,122 | -483 | -1,040 | 224 | 47.00 | 393 | 186,103 | 82,500 | 61,875 | 94.00 | 316 | 454 |
Income Taxes | - | - | - | - | - | 906,396 | - | - | - | 602,909 | 5,743 | 19,133 | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | 23.8% | -801,667 | -1,051,576 | -660,160 | -1,012,951 | -906,396 | -1,662,831 | -983,246 | -658,402 | -602,909 | -1,057,045 | 6,491,571 | -388,807 | -863,735 | - | -556,468 | - | - | - | - | - | - |
EBT Margin | 2.9% | -2.04 | -2.10 | -2.21 | -2.30 | -2.53 | -2.61 | -2.82 | 3.79 | 3.29 | 2.62 | -1.76 | -1.85 | -1.96 | - | - | - | - | - | - | - | - |
Net Income | 28.5% | -801,667 | -1,121,176 | -660,160 | -1,012,951 | -906,396 | -1,662,831 | -983,246 | -658,402 | -604,072 | -1,088,686 | 6,385,119 | -461,990 | -930,702 | -789,814 | -633,795 | -1,375,031 | -238,877 | -382,079 | -265,481 | -242,211 | -123,523 |
Net Income Margin | 2.8% | -2.08 | -2.14 | -2.21 | -2.30 | -2.53 | -2.61 | -2.85 | 3.67 | 3.14 | 2.44 | 2.77 | -1.96 | -2.75 | - | - | - | - | - | - | - | - |
Free Cashflow | 7.9% | -838,179 | -910,012 | -1,071,832 | -549,966 | -692,688 | -885,989 | -1,422,359 | -400,109 | -789,165 | -773,871 | -663,082 | -521,745 | -319,318 | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -10.4% | 6,941 | 7,746 | 8,987 | 10,246 | 11,024 | 11,643 | 13,049 | 9,045 | 9,716 | 10,490 | 11,390 | 5,004 | 5,501 | 1,427 | 2,204 | 2,796 | 404 | 494 | 387 | 536 | 751 |
Current Assets | -10.5% | 6,878 | 7,681 | 8,921 | 10,178 | 10,955 | 11,572 | 12,912 | 8,947 | 9,618 | 10,402 | 11,302 | 4,974 | 5,482 | 1,427 | 2,087 | 2,796 | 404 | 494 | 157 | 306 | 521 |
Cash Equivalents | -24.3% | 2,668 | 3,524 | 200 | 159 | 4,666 | 11,367 | 12,253 | 8,734 | 9,068 | 9,837 | 10,261 | 4,151 | 4,637 | 1,128 | 1,646 | 1,919 | 9.00 | 112 | 25.00 | 77.00 | 177 |
Inventory | - | - | - | - | - | - | - | - | - | - | - | - | 56.00 | 45.00 | 33.00 | 31.00 | 155 | 156 | 156 | 100 | 27.00 | 27.00 |
Liabilities | 5.1% | 1,649 | 1,569 | 1,490 | 1,950 | 1,580 | 1,302 | 1,196 | 1,171 | 1,213 | 1,428 | 1,239 | 1,238 | 1,273 | 146 | 134 | 92.00 | 104 | 117 | - | - | - |
Current Liabilities | 12.6% | 874 | 776 | 679 | 1,120 | 732 | 436 | 312 | 269 | 293 | 490 | 283 | 264 | 327 | 142 | 122 | 80.00 | 266 | 117 | 88.00 | 33.00 | 58.00 |
Shareholder's Equity | -14.3% | 5,292 | 6,177 | 7,497 | 8,296 | 9,444 | 10,341 | 11,853 | 7,874 | 8,503 | 9,062 | 10,151 | 3,766 | 4,228 | 1,281 | 2,071 | 2,304 | - | - | - | 103 | 293 |
Retained Earnings | -7.4% | -11,673 | -10,871 | -9,750 | -9,090 | -8,077 | -7,171 | -5,508 | -4,525 | -3,866 | -3,262 | -2,173 | -8,559 | -8,097 | -5,762 | -4,972 | -4,338 | -2,894 | -2,655 | -2,273 | -2,008 | -1,766 |
Additional Paid-In Capital | 0% | 17,526 | 17,526 | 17,410 | 17,405 | 17,516 | 17,512 | 17,361 | 12,399 | 12,410 | 12,325 | 12,315 | 12,315 | 12,316 | 7,043 | 7,035 | 6,635 | 2,631 | 2,631 | 2,170 | 2,109 | 2,056 |
Shares Outstanding | -2.2% | 2,844 | 2,906 | 3,109 | 3,109 | 3,159 | 3,159 | 2,001 | 1,988 | 1,973 | 1,973 | 1,973 | 1,821 | 1,703 | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 5,962 | - | - | - | 10,084 | - | - | - | 24,840 | - | - | - | 23,749 | - | - | - | 7,128 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 7.9% | -838 | -910 | -1,071 | -549 | -692 | -885 | -1,422 | -400 | -789 | -773 | -663 | -521 | -319 | -536 | -280 | -222 | -117 | -292 | -200 | -151 | -149 |
Share Based Compensation | 7.7% | 173 | 161 | 379 | 169 | 162 | 254 | 97.00 | 100 | 127 | 173 | 55.00 | 55.00 | 112 | 39.00 | 37.00 | 649 | 31.00 | 116 | 87.00 | 86.00 | 30.00 |
Cashflow From Investing | -97.8% | 98.00 | 4,429 | 1,259 | -3,826 | -6,008 | - | - | 67.00 | 20.00 | 349 | 6,774 | 39.00 | 31.00 | 19.00 | 5.00 | - | - | - | 128 | - | - |
Cashflow From Financing | 40.6% | -115 | -194 | -145 | -130 | - | - | - | - | - | - | - | -2.37 | 3,796 | - | 2.00 | 2,118 | 15.00 | 380 | 20.00 | -7.46 | -9.81 |
Buy Backs | - | - | - | - | 131 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
LICENSE FEE REVENUE | $ 18,026 | $ 18,026 |
COST OF REVENUES | 1,460 | 1,460 |
GROSS PROFIT | 16,566 | 16,566 |
OPERATING EXPENSES: | ||
Compensation expense | 173,346 | 162,257 |
Professional fees | 318,427 | 365,270 |
Research and development | 318,240 | 202,913 |
Insurance expense | 21,704 | 24,645 |
Selling, general and administrative expenses | 64,362 | 64,966 |
Total operating expenses | 896,079 | 820,051 |
LOSS FROM OPERATIONS | (879,513) | (803,485) |
OTHER INCOME (EXPENSE): | ||
Interest and dividend income, net | 88,177 | 64,388 |
Interest expense | (1,870) | (1,655) |
Net realized gain on short-term investments | 234 | |
Penalty from early termination of certificate of deposit | (166,034) | |
Net unrealized gain on equity investments | 390 | |
Foreign currency transaction loss | (8,695) | |
Total other income (expense) | 77,846 | (102,911) |
LOSS BEFORE PROVISION FOR INCOME TAXES | (801,667) | (906,396) |
Provision for income taxes | ||
NET LOSS | (801,667) | (906,396) |
COMPREHENSIVE LOSS: | ||
Net loss | (801,667) | (906,396) |
Other comprehensive income (loss): | ||
Unrealized gain on short-term investments | 32,331 | 5,239 |
Total comprehensive loss | $ (769,336) | $ (901,157) |
NET LOSS PER COMMON SHARE: | ||
Basic (in Dollars per share) | $ (0.28) | $ (0.29) |
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: | ||
Basic (in Shares) | 2,866,934 | 3,158,797 |
Consolidated Balance Sheets - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
CURRENT ASSETS: | ||
Cash and cash equivalents | $ 2,668,273 | $ 3,524,308 |
Short-term investments | 4,075,849 | 4,140,880 |
Prepaid expenses and other current assets | 133,764 | 15,970 |
Total Current Assets | 6,877,886 | 7,681,158 |
Prepaid expenses and other assets - non-current | 63,523 | 64,983 |
Total Assets | 6,941,409 | 7,746,141 |
CURRENT LIABILITIES: | ||
Accounts payable and accrued expenses | 801,570 | 703,488 |
Deferred revenue - current portion | 72,102 | 72,102 |
Total Current Liabilities | 873,672 | 775,590 |
LONG TERM LIABILITIES: | ||
Deferred revenue - long-term portion | 775,654 | 793,680 |
Total Long Term Liabilities | 775,654 | 793,680 |
Total Liabilities | 1,649,326 | 1,569,270 |
Commitment and Contingencies (see Note 7) | ||
STOCKHOLDERS’ EQUITY: | ||
Preferred stock, $0.0001 par value, 5,000,000 shares authorized: none designated as of March 31, 2024 and December 31, 2023 | ||
Common stock, $0.0001 par value, 100,000,000 shares authorized; 3,159,096 and 3,159,096 shares issued and 2,833,451 and 2,906,241 shares outstanding at March 31, 2024 and December 31, 2023, respectively | 316 | 316 |
Additional paid-in capital | 17,525,714 | 17,525,714 |
Treasury stock, at cost (325,645 and 252,855 shares on March 31, 2024 and December 31, 2023, respectively) | (586,573) | (471,121) |
Accumulated other comprehensive income (loss) | 26,104 | (6,227) |
Accumulated deficit | (11,673,478) | (10,871,811) |
Total Stockholders’ Equity | 5,292,083 | 6,176,871 |
Total Liabilities and Stockholders’ Equity | $ 6,941,409 | $ 7,746,141 |